HAG
ITCI
HighPoint Advisor Group’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,245
| Closed | -$286K | – | 697 |
|
|
2024
Q4 | $286K | Sell |
2,245
-669
| -23% | -$85.3K | 0.02% | 523 |
|
|
2024
Q3 | $252K | Buy |
2,914
+86
| +3% | +$7.44K | 0.01% | 552 |
|
|
2024
Q2 | $221K | Sell |
2,828
-884
| -24% | -$69.1K | 0.01% | 558 |
|
|
2024
Q1 | $246K | Buy |
3,712
+513
| +16% | +$34K | 0.02% | 528 |
|
|
2023
Q4 | $217K | Buy |
+3,199
| New | +$217K | 0.02% | 569 |
|